Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris
Top Cited Papers
- 31 October 2007
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 57 (4), 622-628
- https://doi.org/10.1016/j.jaad.2007.05.024
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The role of IVIg treatment in severe pemphigus vulgarisJournal of the European Academy of Dermatology and Venereology, 2006
- Prolonged Clinical Remission of Patients with Severe Pemphigus upon Rapid Removal of Desmoglein-Reactive Autoantibodies by ImmunoadsorptionDermatology, 2006
- Tratamiento de pénfigo vulgar grave resistente con rituximabActas Dermo-Sifiliograficas, 2006
- IVIg TREATMENT OF PEMPHIGUS: How it Works and How to Use itJournal of Investigative Dermatology, 2005
- Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigusBritish Journal of Dermatology, 2005
- Treatment of Pemphigus Vulgaris with Protein A Immunoadsorption: Case Report of Long-Term History Showing Favorable OutcomeAnnals of the New York Academy of Sciences, 2005
- Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgarisJournal of the American Academy of Dermatology, 2003
- Treatment of pemphigus with intravenous immunoglobulinJournal of the American Academy of Dermatology, 2002
- Corticosteroid-Sparing Effect of Intravenous Immunoglobulin Therapy in Patients With Pemphigus VulgarisArchives of Dermatology, 2002
- Ineffectiveness of Cyclosporine as an Adjuvant to Corticosteroids in the Treatment of PemphigusArchives of Dermatology, 2000